|
|
|
Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 53-57
|
|
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
GEMCITABINE;
MITOMYCIN;
PACLITAXEL;
PROTEIN P53;
ADVANCED CANCER;
APOPTOSIS;
BLOOD TOXICITY;
CANCER RADIOTHERAPY;
CELL CYCLE;
CLINICAL TRIAL;
DRUG HYPERSENSITIVITY;
GASTRECTOMY;
GENE MUTATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LOWER ESOPHAGUS SPHINCTER;
NEUTROPENIA;
PANCREAS ADENOCARCINOMA;
PANCREATICODUODENECTOMY;
PRIORITY JOURNAL;
RADIATION DOSE;
REVIEW;
STOMACH ADENOCARCINOMA;
TUMOR SUPPRESSOR GENE;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
DIGESTIVE SYSTEM NEOPLASMS;
ESOPHAGEAL NEOPLASMS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PANCREATIC NEOPLASMS;
RADIATION-SENSITIZING AGENTS;
STOMACH NEOPLASMS;
|
|
EID: 0032926239
PISSN: 10534296
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (28)
|
|
References (25)
|
